RxDoctor Payments Data

Asma Khapra

Gastroenterology · Fairfax, VANPI 1770702011

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (37.6%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 41 manufacturers reported payments, led by Johnson & Johnson at 58.7% of the total. 2025 is the largest year on record at $25,915, more than ten times the $741 reported in 2019. Among gastroenterology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$49,013in general payments, 2019–2025

Across 495 payments — averaging $99.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$29K
  • Ardelyx, Inc.$3K
  • Janssen Global Services, LLC$3K
  • AbbVie$2K
  • Mahana Therapeutics, Inc.$2K
  • Genentech USA, Inc.$2K
  • plus $8K from 35 others

What the payments were for

  • Consulting fees$16,70634%
  • Speaking & faculty fees$18,43438%
  • Travel & lodging$3,5137%
  • Food & beverage$10,27921%
  • Education$810%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$49,013 in reported general payments places this provider in the 95th percentile of 473 gastroenterology providers in Virginia.

See all gastroenterology providers in Virginia

Medicare billing

Part B allowed, 2024
$232,829
Medicare patients
515
Services billed
4,305

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide16$22,785
Mesalamine22$15,514
Dexlansoprazole DrDexlansoprazole27$8,368
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates48$2,814
SutabSod Sulf/Pot Chloride/Mag Sulf13$2,123
Famotidine82$1,465
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl85$1,078
Budesonide DrBudesonide11$958
Pantoprazole Sodium56$945
Sucralfate20$832
Omeprazole62$793
Esomeprazole Magnesium12$331
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl16$223
Lactulose20$214

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$2,402$22,78516 claims
Braintree Laboratories, Inc.Sutab$238$2,12313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 473 gastroenterology providers in Virginia.

Other gastroenterology in Fairfax

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →